King Pharmaceuticals KG Income Statement
| FY'25 | ||
|---|---|---|
| —— | ||
| $12.67M— | ||
| $34.05M+785% | ||
| $29.06M+469% | ||
| $24K— | ||
| $6.96M— | ||
| —— | ||
| —— | ||
| —— | ||
| —— | ||
| -$5,000.49— | ||
| —— | ||
| —— | ||
| 20.9M— | ||
| 20.9M— | ||
| $6.46M— | ||
| $6.09M— | ||
| $6.21M— | ||
| $8.99M— | ||
| —— | ||
| —— | ||
| -$0.43— | ||
| —— | ||
| -$2.95M— | ||
| $3.13M— | ||
| $281K— | ||
| $6.08M+67.2% | ||
| —— | ||
| —— | ||
| -$18.74M-1,093% | ||
| -$54.28M— | ||
| —— | ||
| $9.87M— | ||
| $8.34M+3,817% | ||
| —— | ||
| $146.95M— | ||
| -$96.14M— | ||
| -$93.19M— | ||
| $21K— | ||
| $1.08M— | ||
| $6.21M— | ||
| $2.95M— | ||
| $62.79M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is King Pharmaceuticals's revenue?
- King Pharmaceuticals (KG) generated $43.4M in revenue over the trailing twelve months, up 1160.2% year over year.
- Is King Pharmaceuticals profitable?
- King Pharmaceuticals reported $57.0M in net income over the trailing twelve months, a 131.4% net margin.
- What is King Pharmaceuticals's earnings per share?
- King Pharmaceuticals's diluted EPS over the trailing twelve months is $13.30.
- Where does King Pharmaceuticals's income statement data come from?
- Every line is extracted from King Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
